Clinical trials
Observational Non-Radiographic Axial Spondyloarthritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Ankara University | 1 |
| Celltrion HealthCare France | 1 |
| Charite University, Berlin, Germany | 1 |
| Royal United Hospitals Bath NHS Foundation Trust | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Southwest Hospital, China | 1 |
| TScan Therapeutics, Inc. | 1 |
| UCB Biopharma S.P.R.L. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Radiographic Axial Spondyloarthritis | 12 |
| Spondylitis, Ankylosing | 11 |
| Axial Spondyloarthritis | 6 |
| Colitis, Ulcerative | 5 |
| Arthritis, Psoriatic | 4 |
| Crohn Disease | 4 |
| Arthritis, Rheumatoid | 2 |
| Uveitis, Anterior | 2 |
| Arthritis, Juvenile | 1 |
| Arthritis, Reactive | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.